Dana-Farber/Boston Children's Cancer and Blood Disorders Center researchers initiate multiple new pediatric cancer clinical studies each year, investigating new treatments for all forms of childhood cancer. Many of our findings have built the foundation for the newest medications and state-of-the-art procedures we use to treat childhood cancer. For children with relapsed or refractory cancers, clinical trials may also provide a new treatment option where traditional options have failed.
Participation in clinical trials is completely voluntary. Before your child begins a trial, we will fully explain all parts of the treatment plan and fill out formal consent forms. You may remove your child from the medical study at any time.